Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 545.47 Million EUR | -1.96% |
| 2022 | 597.45 Million EUR | 19.07% |
| 2021 | 501.76 Million EUR | 38.41% |
| 2020 | 362.52 Million EUR | -23.98% |
| 2019 | 476.88 Million EUR | 5.22% |
| 2018 | 453.21 Million EUR | -12.77% |
| 2017 | 519.54 Million EUR | -27.4% |
| 2016 | 715.62 Million EUR | -5.46% |
| 2015 | 756.95 Million EUR | 5.34% |
| 2014 | 718.55 Million EUR | 5.1% |
| 2013 | 683.69 Million EUR | 0.59% |
| 2012 | 679.67 Million EUR | 4.2% |
| 2011 | 652.28 Million EUR | 3.55% |
| 2010 | 629.91 Million EUR | 10.03% |
| 2009 | 572.48 Million EUR | -13.65% |
| 2008 | 662.95 Million EUR | -5.0% |
| 2007 | 697.83 Million EUR | 5.18% |
| 2006 | 663.47 Million EUR | 8.99% |
| 2005 | 608.76 Million EUR | 8.09% |
| 2004 | 563.21 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 325.16 Million USD | 0.0% |
| 2023 FY | 585.73 Million EUR | -1.96% |
| 2023 Q4 | 268.18 Million USD | 92.84% |
| 2023 Q3 | 139.06 Million EUR | -57.85% |
| 2023 Q2 | 329.93 Million USD | 103.92% |
| 2023 Q1 | 161.79 Million EUR | -42.23% |
| 2022 Q2 | 159.15 Million USD | 0.0% |
| 2022 Q4 | 280.07 Million USD | 100.67% |
| 2022 FY | 597.45 Million EUR | 19.07% |
| 2022 Q1 | 159.15 Million EUR | 31.54% |
| 2022 Q3 | 139.56 Million EUR | -12.31% |
| 2021 Q3 | 120.98 Million EUR | -10.59% |
| 2021 Q2 | 135.31 Million USD | 0.0% |
| 2021 FY | 501.76 Million EUR | 38.41% |
| 2021 Q1 | 135.31 Million EUR | 25.59% |
| 2021 Q4 | 120.98 Million USD | 0.0% |
| 2020 Q3 | 107.74 Million EUR | 42.27% |
| 2020 FY | 362.52 Million EUR | -23.98% |
| 2020 Q1 | 75.73 Million EUR | -30.31% |
| 2020 Q2 | 75.73 Million USD | 0.0% |
| 2020 Q4 | 107.74 Million USD | 0.0% |
| 2019 Q3 | 108.68 Million EUR | -61.82% |
| 2019 Q1 | 133.07 Million EUR | 24.72% |
| 2019 FY | 476.88 Million EUR | 5.22% |
| 2019 Q2 | 284.69 Million EUR | 113.93% |
| 2019 Q4 | 108.68 Million USD | 0.0% |
| 2018 Q3 | 106.7 Million EUR | -11.01% |
| 2018 Q4 | 106.7 Million EUR | 0.0% |
| 2018 FY | 453.21 Million EUR | -12.77% |
| 2018 Q1 | 119.9 Million EUR | 3.22% |
| 2018 Q2 | 119.9 Million EUR | 0.0% |
| 2017 Q1 | 143.6 Million EUR | -10.53% |
| 2017 Q4 | 116.17 Million EUR | 0.0% |
| 2017 Q3 | 116.17 Million EUR | -19.1% |
| 2017 FY | 519.54 Million EUR | -27.4% |
| 2017 Q2 | 143.6 Million EUR | 0.0% |
| 2016 FY | 715.62 Million EUR | -5.46% |
| 2016 Q2 | 197.3 Million EUR | 0.0% |
| 2016 Q4 | 160.5 Million EUR | 0.0% |
| 2016 Q3 | 160.5 Million EUR | -18.65% |
| 2016 Q1 | 197.3 Million EUR | 9.9% |
| 2015 FY | 756.95 Million EUR | 5.34% |
| 2015 Q4 | 179.52 Million EUR | 7.18% |
| 2015 Q3 | 167.49 Million EUR | -21.51% |
| 2015 Q2 | 213.38 Million EUR | 8.56% |
| 2015 Q1 | 196.55 Million EUR | 10.45% |
| 2014 Q1 | 184.04 Million EUR | 10.31% |
| 2014 Q4 | 177.95 Million EUR | 13.31% |
| 2014 Q3 | 157.05 Million EUR | -21.27% |
| 2014 Q2 | 199.49 Million EUR | 8.39% |
| 2014 FY | 718.55 Million EUR | 5.1% |
| 2013 FY | 683.69 Million EUR | 0.59% |
| 2013 Q2 | 192.33 Million EUR | 7.03% |
| 2013 Q4 | 166.85 Million EUR | 15.22% |
| 2013 Q1 | 179.69 Million EUR | 5.36% |
| 2013 Q3 | 144.81 Million EUR | -24.71% |
| 2012 Q1 | 174.18 Million EUR | 12.59% |
| 2012 Q3 | 143.77 Million EUR | -24.78% |
| 2012 Q4 | 170.56 Million EUR | 18.63% |
| 2012 FY | 679.67 Million EUR | 4.2% |
| 2012 Q2 | 191.14 Million EUR | 9.73% |
| 2011 Q2 | 181.26 Million EUR | -0.96% |
| 2011 Q4 | 154.71 Million EUR | 16.09% |
| 2011 FY | 652.28 Million EUR | 3.55% |
| 2011 Q3 | 133.27 Million EUR | -26.48% |
| 2011 Q1 | 183.03 Million EUR | 24.37% |
| 2010 Q2 | 172.95 Million EUR | -0.36% |
| 2010 FY | 629.91 Million EUR | 10.03% |
| 2010 Q3 | 136.21 Million EUR | -21.24% |
| 2010 Q1 | 173.58 Million EUR | 37.67% |
| 2010 Q4 | 147.16 Million EUR | 8.04% |
| 2009 Q1 | 174.57 Million EUR | 0.0% |
| 2009 FY | 572.48 Million EUR | -13.65% |
| 2009 Q4 | 126.08 Million EUR | 9.41% |
| 2009 Q3 | 115.24 Million EUR | -26.4% |
| 2009 Q2 | 156.57 Million EUR | -10.31% |
| 2008 FY | 662.95 Million EUR | -5.0% |
| 2007 FY | 697.83 Million EUR | 5.18% |
| 2006 FY | 663.47 Million EUR | 8.99% |
| 2005 FY | 608.76 Million EUR | 8.09% |
| 2004 FY | 563.21 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -32003.393% |
| Ansell Limited | 624.8 Million USD | 12.697% |
| Ansell Limited | 624.8 Million USD | 12.697% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -378.727% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -403788.046% |
| Psykey, Inc. | 415.97 Thousand USD | -131030.402% |
| ConvaTec Group Plc | 1.2 Billion USD | 54.661% |
| ConvaTec Group Plc | 1.17 Billion USD | 53.569% |
| Encision Inc. | 3.13 Million USD | -17294.056% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -68597.994% |
| LifePoint, Inc. | -71.35 Thousand USD | 764514.642% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 416490.076% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -103799.238% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -90323.546% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -91357.377% |
| SmileDirectClub, Inc. | 275.84 Million USD | -97.744% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 39.441% |
| SheerVision, Inc. | 2.17 Million USD | -24968.649% |
| United Health Products, Inc. | -4857.00 USD | 11230715.606% |
| Vasamed, Inc. | -69.38 Thousand USD | 786217.196% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -203690.214% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1035892.935% |